Inhibitory CD8+ T cells in autoimmune disease
Authors:
- Christine KonyaCKChristine Konya
- Jörg J. GoronzyJGJörg J. Goronzy
- Cornelia M. WeyandCWCornelia M. Weyand
- 1 November 2008
- journal article
- review article
- Published by Elsevier in Human Immunology
- Vol. 69 (11) , 781-789
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- The Interleukin‐23 / Interleukin‐17 axis in intestinal inflammationJournal of Internal Medicine, 2008
- Emerging concepts in CD8+ T regulatory cellsCurrent Opinion in Immunology, 2008
- Atherosclerosis and systemic lupus erythematosus — mechanistic basis of the associationCurrent Opinion in Immunology, 2007
- The role of CD8+CD28−regulatory cells in suppressing myasthenia gravis-associated responses by a dual altered peptide ligandProceedings of the National Academy of Sciences, 2007
- Identification of a human CD8+regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4Proceedings of the National Academy of Sciences, 2007
- Transient regulatory T-cells: A state attained by all activated human T-cellsClinical Immunology, 2007
- Regulatory T Cells and Human DiseaseJournal of Immunology Research, 2007
- CD8+CD28− Regulatory T Lymphocytes Prevent Experimental Inflammatory Bowel Disease in MiceGastroenterology, 2006
- Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell developmentProceedings of the National Academy of Sciences, 2006
- Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28− T cells and inhibit both T-Cell proliferation and CTL functionHuman Immunology, 2004